Expired Tender USA ICB TOT Ref. 26584880

Utilizing the PLCO Biospecimens Resource to Bridge Tender - 26584880

Tender notice from USA, published on 10 Sep 2018.

Executive Summary

The NATIONAL INSTITUTES OF HEALTH has issued a Tender notice for the procurement of a Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01 Clinical Trial Not Allowed) in the USA. This Tender notice was published on 10 Sep 2018 and is scheduled to close on 11 Aug 2021, with an estimated Tender value of Refer Document. Interested bidders can access detailed Tender information, eligibility criteria, and complete bidding documents by referencing TOT Ref No. 26584880, while the tender notice number is PAR-18-913 and Register on the platform.

Key facts

Summary
Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01 Clinical Trial Not Allowed)
TOT Ref. No.
26584880
Document Ref. No.
PAR-18-913
Country
USA
Notice type
Tender
Competition
ICB
Publication date
10 Sep 2018
Bid deadline
11 Aug 2021
EMD
Refer Document
Tender value
Refer Document
Purchaser ownership
-
Financier
Self Financed

CPV classification

Purchaser details

Purchaser contact is for registered users

Login to see details

Tender details

Tender are invited for Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01 Clinical Trial Not Allowed)
CFDA Number : 93.393 -- Cancer Cause and Prevention Research
Cost Sharing or Matching Requirement : No
Closing Date for Applications: Aug 11, 2021
Posted Date : Sep 07, 2018
Description: This Funding Opportunity Announcement (FOA) encourages the submission of applications that propose to advance research in cancer etiology and early detection biomarkers, utilizing the advantages of the unique biorepository resources of the NCI-sponsored Prostate, Lung, Colorectal, and Ovarian Cancer (PLCO) Screening Trial. The PLCO Biorepository offers high-quality, prospectively collected, serial pre-diagnostic blood samples from the PLCO screened arm participants, and a onetime collection of buccal cells from the control arm participants. Available data associated with the biospecimens includes demographic, diet, lifestyle, smoking, screening results, and clinical data. This FOA supports a wide range of cancer research including, but not limited to, biochemical and genetic analyses of cancer risk, as well as discovery and validation of early detection biomarkers. The proposed research project must involve use of PLCO biospecimens; additionally, it should also take advantage of the unique characteristics of the PLCO biospecimens. Research projects that do not involve the use of PLCO biospecimens will not be supported under this FOA.

Documents

Tender Notice
Login to view

USA Public Procurement Intelligence

Frequently asked questions

The bid deadline for Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01 Clinical Trial Not Allowed) was 11 Aug 2021. Bidding is closed.

This tender has been issued by NATIONAL INSTITUTES OF HEALTH in USA.

The tender value is not disclosed; please refer to the tender document. EMD / bid security details are provided in the tender document.

This tender is Self Financed

The tender is classified under the following CPV code(s): 44212100 - Bridge.

The tender notice and related documents are listed in the Documents section above. Select a document to view or download it. Please log in or register to access the documents. If you cannot find additional documents in the Documents section, please log in to your account and Send Document Request from your account section.

The TendersOnTime reference is 26584880. The purchaser document reference is PAR-18-913.

Browse other tenders from USA or search by relevant keywords and CPV classification.